Multisystem inflammatory syndrome (MIS-C) with SARS-CoV-2 omicron variant BA.2.38 in a four-year-old Chinese girl: A

Wen-Yuan Wang1, Yong-Jun Wang1, Cai-Xia An1

  • 1Pediatric Respiratory Department II, Gansu Provincial Maternity and Child-Care Hospital, Lanzhou, China.

Frontiers in Public Health
|November 28, 2022
PubMed

Insights

A severe case of COVID-19 in a child also developed Multisystem Inflammatory Syndrome (MIS-C). This report details the diagnosis and treatment of MIS-C in pediatric patients.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Immunology

Background:

  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can lead to various complications in children.
  • Multisystem Inflammatory Syndrome in Children (MIS-C) is a rare but serious condition associated with COVID-19.

Observation:

  • A previously healthy 4-year-old girl presented with fever.
  • The child was diagnosed with severe COVID-19 complicated by MIS-C.

Findings:

  • This case highlights the potential for severe COVID-19 to trigger MIS-C in pediatric populations.
  • The report reviews current research on MIS-C diagnosis and therapeutic strategies.

Implications:

  • Early recognition and diagnosis of MIS-C are crucial for timely intervention in children.
  • Understanding the pathophysiology and management of MIS-C is essential for pediatric healthcare providers.